Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION. (Tables)

v3.20.1
STOCK-BASED COMPENSATION. (Tables)
 12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of option activity

The status of Company's stock option plans as of December 31, 2019 and 2018 and of changes in options outstanding under the Company's plans during those years are as follows (number of shares in thousands):

 

    Years Ended December 31,  
    2019     2018  
    Number
of Shares		     Weighted Average Exercise Price     Number
of Shares		     Weighted Average
Exercise Price		  
Outstanding at beginning of year     229     $ 4.15       230     $ 4.18  
Options cancelled     —       —       (1 )     12.90  
Outstanding at end of year     229     $ 4.15       229     $ 4.15  
Options exercisable at end of year     229     $ 4.15       229     $ 4.15  
Schedule of stock options by exercise price range

Stock options outstanding as of December 31, 2019 were as follows (number of shares in thousands): 

 

      Options Outstanding     Options Exercisable  
Range of
Exercise Prices		     Number
Outstanding		     Weighted Average Remaining Contractual Life (yrs.)     Weighted
Average
Exercise
Price		     Number Exercisable     Weighted
Average
Exercise
Price		  
                                 
$ 3.74       219       3.47     $ 3.74       219     $ 3.74  
$ 12.90       10       1.59     $ 12.90       10     $ 12.90  
Schedule of unvested restricted stock activity

The Company granted to certain employees and directors shares of restricted stock under its 2006 and 2016 Stock Incentive Plans. A summary of unvested restricted stock activity is as follows (shares in thousands):

 

    Number of
Shares		     Weighted
Average
Grant Date
Fair Value
Per Share		  
Unvested at December 31, 2018     1,635     $ 3.49  
Issued     1,434     $ 1.01  
Vested     (669 )   $ 3.96  
Canceled     (199 )   $ 2.31  
Unvested at December 31, 2019     2,201     $ 1.84  
Schedule of stock-based compensation expense

Stock-based compensation expense related to employee and non-employee restricted stock and option grants recognized in selling, general and administrative expenses, were as follows (in thousands):

 

    Years Ended December 31,  
    2019     2018  
Employees   $ 2,422     $ 2,905  
Non-employees     387       533  
Total stock-based compensation expense   $ 2,809     $ 3,438